LSIPR webinar: No end in sight for CRISPR IP saga, says HGF
Press releases in recent months that suggest the CRISPR IP saga is about to end are too optimistic and miss out many of the nuances of the current situation, according to Claire Irvine, partner at HGF.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
11 September 2018 The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology.
23 November 2018 The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.
23 November 2018 The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.
11 September 2018 The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology.
23 November 2018 The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.
11 September 2018 The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology.